Clinical trial
BAROSTIM NEO Hypertension Pivotal Trial
NCT01679132 · CVRx, Inc., Industry · Suspended
Key facts
| NCT number | NCT01679132 |
|---|---|
| Title | BAROSTIM NEO Hypertension Pivotal Trial |
| Official title | BAROSTIM NEO Hypertension Pivotal Trial |
| Lead sponsor | CVRx, Inc., Industry |
| Status | Suspended |
| Study type | Interventional |
| Conditions | Uncontrolled Hypertension |
| Intervention type | Device |
| Interventions | BAROSTIM NEO System and Medical Management |
| Enrollment | 10 |
| Start date | Apr 12, 2013 |
| Primary completion | Mar 1, 2026 |
| Completion | Mar 1, 2026 |
| First posted | Sep 5, 2012 |
| Last update posted | Jul 15, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: